Asset formula

Shares of The Clorox Company (NYSE:CLX) sold by Robeco Institutional Asset Management BV


Robeco Institutional Asset Management BV reduced its holdings in The Clorox Company (NYSE:CLX – Get Rating) by 0.1% in the first quarter, according to the company in its most recent Form 13F filed with the Securities and Exchange Commission (SEC). The company held 116,860 shares of the company after selling 100 shares during the quarter. Robeco Institutional Asset Management BV held approximately 0.10% of Clorox worth $16,248,000 at the end of the last quarter.

Other institutional investors have also increased or reduced their stake in the company. Newbridge Financial Services Group Inc. increased its stake in Clorox by 185.2% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 154 shares of the company worth $27,000 after purchasing an additional 100 shares during the period. TAP Consulting LLC acquired a new position in Clorox in the fourth quarter worth $27,000. FSB Premier Wealth Management Inc. acquired a new position in Clorox in the fourth quarter worth $28,000. Financial Avengers Inc. increased its stake in Clorox by 119.7% in the fourth quarter. Financial Avengers Inc. now owns 167 shares of the company valued at $29,000 after buying 91 additional shares in the last quarter. Finally, Lumature Wealth Partners LLC increased its stake in Clorox by 74.0% in the fourth quarter. Lumature Wealth Partners LLC now owns 167 shares of the company valued at $29,000 after purchasing 71 additional shares in the last quarter. 77.28% of the shares are held by hedge funds and other institutional investors.

A number of equity research analysts have published reports on CLX shares. Goldman Sachs Group reduced its target price on Clorox from $145.00 to $127.00 in a Tuesday, March 29 research note. Deutsche Bank Aktiengesellschaft cut its price target on Clorox from $145.00 to $132.00 and placed a “hold” rating on the stock in a Tuesday, June 21 research note. JPMorgan Chase & Co. raised its price target on Clorox from $123.00 to $126.00 in a Thursday, April 14 research note. Barclays reduced its target price on Clorox from $126.00 to $115.00 and set an “underweight” rating on the stock in a Monday May 23 research note. Finally, DA Davidson reduced his target price on Clorox from $127.00 to $123.00 in a Tuesday, May 3 research note. Nine research analysts gave the stock a sell rating, five gave the stock a hold rating and one gave the stock a buy rating. According to data from MarketBeat, Clorox currently has an average rating of “Reduce” and an average target price of $140.69.

In related news, Director A D. David Mackay sold 1,000 shares of Clorox in a trade dated Thursday, June 2. The stock was sold at an average price of $140.63, for a total value of $140,630.00. Following the transaction, the director now owns 600 shares of the company, valued at approximately $84,378. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available on the SEC’s website. Additionally, COO Eric H. Reynolds sold 585 shares of Clorox in a trade dated Monday, May 9. The stock was sold at an average price of $154.83, for a total value of $90,575.55. Following completion of the transaction, the COO now directly owns 17,289 shares of the company, valued at approximately $2,676,855.87. The disclosure of this sale can be found here. 0.58% of the shares are currently held by insiders.

Clorox shares opened at $141.36 on Monday. The company has a current ratio of 0.71, a quick ratio of 0.40 and a debt ratio of 3.28. The company’s 50-day moving average price is $141.40 and its two-hundred-day moving average price is $148.90. The Clorox Company has a 52 week low of $120.50 and a 52 week high of $191.75. The stock has a market capitalization of $17.40 billion, a PE ratio of 38.31, a price-to-growth earnings ratio of 3.68 and a beta of 0.19.

Clorox (NYSE:CLX – Get Rating) last released its quarterly results on Monday, May 2. The company reported EPS of $1.31 for the quarter, beating the consensus estimate of $0.97 by $0.34. Clorox had a net margin of 6.44% and a return on equity of 92.98%. The company posted revenue of $1.81 billion for the quarter, versus $1.81 billion for analysts. In the same period a year earlier, the company had earned earnings per share of $1.62. On average, stock analysts predict The Clorox Company will post an EPS of 4.16 for the current fiscal year.

Clorox Company Profile (Get a rating)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle and International. The Health and Wellness segment offers cleaning products, such as laundry additives and household cleaning products, primarily under the brands Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex and Formula 409; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare and Clorox Total 360 brands; professional catering products under the Hidden Valley brand; and vitamins, minerals and supplements under the RenewLife, Natural Vitality, NeoCell and Rainbow Light brands in the United States.

Read more

Want to see which other hedge funds hold CLX? Visit HoldingsChannel.com for the latest 13F filings and insider trading for The Clorox Company (NYSE:CLX – Get Rating).

Institutional ownership by quarter for Clorox (NYSE:CLX)



Get news and reviews for Clorox Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Clorox and related companies with MarketBeat.com’s FREE daily newsletter.


Source link